M&A Deal Summary

KKR Acquires Bushu Pharma

On December 20, 2022, private equity firm KKR acquired life science company Bushu Pharma from Baring Private Equity Asia

Acquisition Highlights
  • This is KKR’s 17th transaction in the Life Science sector.
  • This is KKR’s 11th transaction in Japan.

M&A Deal Summary

Date 2022-12-20
Target Bushu Pharma
Sector Life Science
Buyer(s) KKR
Sellers(s) Baring Private Equity Asia
Deal Type Secondary Buyout

Target

Bushu Pharma

Saitama, Japan
website
Bushu Pharma is an independent pharmaceutical contract manufacturer that carries out pharmaceutical drug product contract manufacturing and packaging of clinical trials and commercial products in accordance with the latest GMP standards. Through the utilization of know-how and the latest industry information, the company prides itself on being able to offer added-value solutions to customers. Bushu Pharma was formed in 1998 and is based in Saitama, Japan.

Search 191,421 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

KKR

New York, New York, United States

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 1976
PE ASSETS 510.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION
KKR's office in Menlo Park, California.
KKR's office in Menlo Park, California.

KKR is a global investment firm founded by Jerome Kohlberg, Henry Kravis, and George Roberts. The Firm is separated into several business segments including private markets, public markets, capital markets, and other principal activities. KKR's private equity practice invests in management buyouts, take privates, corporate divestitures, industry consolidations, and partnerships with family-owned companies. KKR will invest in a broad range of industries and companies and will consider businesses throughout North America, Europe, Asia, and Australia/New Zealand. Sectors of interest include chemicals, consumer products, energy and natural resources, financial services, healthcare, industrial, media/communications, retail, and technology. In addition to its traditional principal investment activity business, KKR also invests in infrastructure assets. KKR was formed in 1976 and is based in New York, New York.


DEAL STATS #
Overall 414 of 426
Sector (Life Science) 17 of 17
Type (Secondary Buyout) 96 of 100
Country (Japan) 11 of 11
Year (2022) 16 of 16
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-12-06 Clinisupplies

Watford, United Kingdom

Clinisupplies is a manufacturer and supplier of medical appliances specializing in continence products for managing acute and chronic conditions. The company also offers a portfolio of bandages and garments for the treatment of wounds and chronic skin conditions. Clinisupplies supplies its products to the NHS and delivers directly to patients’ homes through Clinidirect, its dispensing appliance contractor. It is focused on developing products that are simple and discreet to use. Clinisupplies is based in Watford, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-01-17 Acufocus

Irvine, California, United States

Acufocus is a medical device company that develops and markets small aperture technologies for the improvement of near vision. Acufocus was founded in 2001 and is based in Irvine, California.

Sell -

Seller(S) 1

SELLER

Baring Private Equity Asia

Hong Kong, China

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 1997
PE ASSETS 17.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Baring Private Equity Asia is an Asia-focused private equity group specializing in growth equity investments and buyouts of companies valued between $300 million and $1.5 billion. Baring looks for companies that require capital for organic expansion, recapitalizations, or to fund acquisitions. The Group's geographic coverage spans China, India, Japan, Singapore, Hong Kong, and Taiwan. Baring Private Equity Asia was formed in 1997 and is based in Hong Kong.


DEAL STATS #
Overall 21 of 21
Sector (Life Science) 1 of 1
Type (Secondary Buyout) 6 of 6
Country (Japan) 5 of 5
Year (2022) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-05-30 Ginko International

Taichung, Taiwan

Ginko International is a contact lens producer. Ginko International's main products include conventional contact lenses, disposable contact lenses, and lens care products. Ginko International was founded in 1985 and is based in Taichung, Taiwan.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-04-25 IMG Academy

Bradenton, Florida, United States

IMG Academy supports the entire student-athlete development journey across its on-campus and online student-athlete education experiences. The Company provides a sports-focused boarding school, sports camps, online coaching, and college recruiting, and is known for its strong outcomes from the Ivy League to professional leagues. IMG Academy was formed in 1978 and is based in Bradenton, Florida.

Buy $1.3B